Neville Rodie & Shaw’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,830
| Closed | -$519K | – | 263 |
|
|
2021
Q2 | $519K | Sell |
3,830
-1,750
| -31% | -$237K | 0.04% | 178 |
|
|
2021
Q1 | $757K | Hold |
5,580
| – | – | 0.06% | 148 |
|
|
2020
Q4 | $786K | Hold |
5,580
| – | – | 0.07% | 136 |
|
|
2020
Q3 | $622K | Buy |
5,580
+2,750
| +97% | +$307K | 0.06% | 144 |
|
|
2020
Q2 | $317K | Buy |
+2,830
| New | +$317K | 0.03% | 186 |
|
|
2019
Q2 | – | Sell |
-2,375
| Closed | -$215K | – | 253 |
|
|
2019
Q1 | $215K | Buy |
+2,375
| New | +$215K | 0.02% | 234 |
|